NYSE
$1
(1.49%)
Subscribe to get
AI Score
Daiwa America lowered shares of AbbVie (NYSE:ABBV – Free Report) from a strong-buy rating to a hold rating in a research report report published on Thursday,Zacks.com reports. Several other ...
AbbVie Inc (ABBV, Financial) announced on December 7, 2024, the updated results from its Phase 1b/2 EPCORE NHL-2 trial, which evaluates the investigational drug epcoritamab in combination with ...
We recently compiled a list of the Dividend Kings List: Top 15. In this article, we are going to...
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Benzinga Pro's real-time newsfeed alerted to latest BMY news AbbVie Inc. ABBV Dividend Yield: 3.61%...
Quantbot Technologies LP bought a new position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) during the 3rd quarter, HoldingsChannel reports. The firm bought 771 shares of the company’s ...
Unlock Cyber Monday savings! As Christmas approaches, so does the much-anticipated "Santa Claus...
Accordingly, the fund pays out a hefty portion of dividends. Its current dividend yield is 8.4%....
AbbVie Inc. (NYSE:ABBV) discovers, develops, manufactures and sells pharmaceuticals worldwide. It...
Some of the best stocks for income investors are the Dividend Kings. Here are five that are perfect...